Readoutin 104d
Viatris Innovation GmbH — Cenerimod
Phase 3 primary completion: A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus.
- Date
- Mar 2027
- Type
- Readout
- Indication
- Lupus Erythematosus, Systemic